FDA Import Refusal SCS-2353174-7/12/1 — M RADHA
The FDA refused shipment SCS-2353174-7/12/1 from M RADHA (India) on Aug 13, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Aug 13, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75